Author(s): Nero TL, Morton CJ, Holien JK, Wielens J, Parker MW
Abstract Share this page
Abstract Historically, targeting protein-protein interactions with small molecules was not thought possible because the corresponding interfaces were considered mostly flat and featureless and therefore 'undruggable'. Instead, such interactions were targeted with larger molecules, such as peptides and antibodies. However, the past decade has seen encouraging breakthroughs through the refinement of existing techniques and the development of new ones, together with the identification and exploitation of unexpected aspects of protein-protein interaction surfaces. In this Review, we describe some of the latest techniques to discover modulators of protein-protein interactions and how current drug discovery approaches have been adapted to successfully target these interfaces.
This article was published in Nat Rev Cancer
and referenced in Journal of Pharmacogenomics & Pharmacoproteomics